Literature DB >> 29420143

Complications of Intravitreous Injections in Patients with Diabetes.

Aditi Gupta1, Jennifer K Sun1,2, Paolo S Silva1,2.   

Abstract

Intravitreous injections are presently the second most frequently performed ophthalmic procedure and the most common vitreoretinal procedure. In diabetic patients, intravitreous injections are frequently performed for the treatment of center-involved diabetic macular edema, proliferative diabetic retinopathy, or other co-existing retinal vascular disease. Diabetic patients may be at higher risk of adverse events compared to non-diabetic individuals, given frequent systemic comorbidities, such as cardiovascular and renal disease and increased susceptibility to infection. This review highlights the potential complications and safety considerations in intravitreous injections in patients with diabetes.

Entities:  

Keywords:  Anti-VEGF; diabetic macular edema; diabetic retinopathy; intravitreal injections; intravitreous injections; steroid

Mesh：

Substances：

Year:  2018        PMID： 29420143     DOI： 10.1080/08820538.2017.1353811

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN： 0882-0538            Impact factor:   1.975


  10 in total

1.  Molecular-Physiological Aspects of Regulatory Effect of Peptide Retinoprotectors.

Authors:  V Khavinson; S Trofimova; A Trofimov; I Solomin
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

2.  Effects of Varying Intranasal Treatment Regimens in ST266-Mediated Retinal Ganglion Cell Neuroprotection.

Authors:  Reas S Khan; Kimberly Dine; Howard Wessel; Larry Brown; Kenneth S Shindler
Journal:  J Neuroophthalmol       Date:  2019-06       Impact factor: 3.042

3.  Comparison of the efficacy and safety of anti-VEGF monotherapy versus anti-VEGF therapy combined with subthreshold micropulse laser therapy for diabetic macular edema.

Authors:  Meltem Guzin Altınel; Banu Acikalin; Meryem Guler Alis; Gokhan Demir; Kemal Mert Mutibayraktaroglu; Ozgun Melike Gedar Totuk; Aylin Ardagil
Journal:  Lasers Med Sci       Date:  2021-04-04       Impact factor: 3.161

4.  The Application of Methylprednisolone Nanoscale Zirconium-Porphyrin Metal-Organic Framework (MPS-NPMOF) in the Treatment of Photoreceptor Degeneration.

Authors:  Yajie Wang; Wei Liu; Bo Yuan; Xuebo Yin; Yiming Li; Zongjin Li; Jianlin Cui; Xiaoyong Yuan; Yuhao Li
Journal:  Int J Nanomedicine       Date:  2019-12-10

5.  Subthreshold yellow laser for fovea-involving diabetic macular edema in a series of patients with good vision: effectiveness and safety of a fovea-sparing technique.

Authors:  Alejandro Filloy; Victor Chong; Eduard Solé
Journal:  BMC Ophthalmol       Date:  2020-07-06       Impact factor: 2.209

6.  Can subthreshold micropulse yellow laser treatment change the anti-vascular endothelial growth factor algorithm in diabetic macular edema? A randomized clinical trial.

Authors:  Hatice Selen Kanar; Aysu Arsan; Ahmet Altun; Suat Fazıl Akı; Aynur Hacısalihoglu
Journal:  Indian J Ophthalmol       Date:  2020-01       Impact factor: 1.848

7.  Efficacy of Sub-Tenon Micro-Perfusion of Cyclophosphamide in Rabbits with Severe Ocular Inflammation.

Authors:  Libei Zhao; Manqiang Peng; Wenxiang Lin; Qian Tan; Muhammad Ahmad Khan; Ding Lin
Journal:  Drug Des Devel Ther       Date:  2020-08-20       Impact factor: 4.162

8.  Beneficial Effect of Long-Term Administration of Supplement With Trapa Bispinosa Roxb. and Lutein on Retinal Neurovascular Coupling in Type 2 Diabetic Mice.

Authors:  Junya Hanaguri; Harumasa Yokota; Akifumi Kushiyama; Sakura Kushiyama; Masahisa Watanabe; Satoru Yamagami; Taiji Nagaoka
Journal:  Front Physiol       Date:  2022-02-24       Impact factor: 4.566

9.  Safety and Biocompatibility of Aflibercept-Loaded Microsphere Thermo-Responsive Hydrogel Drug Delivery System in a Nonhuman Primate Model.

Authors:  Soohyun Kim; Jennifer J Kang-Mieler; Wenqiang Liu; Zhe Wang; Glenn Yiu; Leandro B C Teixeira; William F Mieler; Sara M Thomasy
Journal:  Transl Vis Sci Technol       Date:  2020-02-27       Impact factor: 3.283

10.  Surgical Management of Complications after Dexamethasone Implant.

Authors:  Giancarlo Sborgia; Alfredo Niro; Francesco D'Oria; Alessandra Galeone; Luigi Sborgia; Francesco Boscia; Alessandra Sborgia; Giovanni Alessio
Journal:  Case Rep Ophthalmol Med       Date:  2020-02-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.